ALK and cancer: Anaplastic Lymphoma Kinase (ALK) is an activator of the PI3K/AKT signaling pathway, and it induces phosphorylation of the p55γ subunit of PI3K in cancer cells, rather than the usual p85 subunit that is phosphorylated (128, 129).